登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担个别及连带责任。 重要内容及风险提示： 1.为进一步拓宽融资渠道、开放整合资源，提高华新水泥股份有限公司（以下简称"公司"或"华新水 泥"）的经营能力，华新水泥拟将下属全部实际开展生产经营的境外资产整合至拟由华新水泥或其附属 公司设立的境外子公司（以下简称"拟分拆子公司"）旗下，并拟申请将拟分拆子公司分拆至境外证券交 易所上市（以下简称"本次分拆上市"）。 2.本次分拆上市不会影响华新水泥对相关境外资产的控制权，拟分拆子公司仍为华新水泥合并报表范围 内的控股子公司。 3.考虑到本次分拆上市所涉境外资产整合将涉及较多内外部沟通工作，虽尚处于初步筹划阶段但预计难 以保密，公司董事会同意披露关于筹划本次分拆上市的事项。在本次分拆上市方案制定完成后，相关方 案及与本次分拆上市有关的其他事项将分别提交至公司董事会、股东会审议。 4.本次分拆上市尚处于前期筹划阶段，项目实施过程中会存在各种不确定因素，可能会影响本次分拆上 市的筹划和决策事宜，本次分拆上市事 ...

Core Viewpoint - Huaxin Cement (600801.SH) plans to integrate all its overseas assets into a proposed subsidiary to be established by Huaxin Cement or its affiliates, with the intention of applying for a listing on an overseas stock exchange. This move aims to enhance the company's operational capabilities and competitiveness in the global cement industry [1]. Group 1 - The proposed spin-off subsidiary will help broaden financing channels and integrate resources, thereby improving Huaxin Cement's operational capabilities [1]. - The spin-off is expected to enhance the subsidiary's competitiveness and flexibility in financing and merger transactions in overseas capital markets [1]. - This initiative aligns with Huaxin Cement's long-term strategic goal of becoming a leading multinational building materials enterprise [1]. Group 2 - The spin-off will not affect Huaxin Cement's control over the relevant overseas assets, as the proposed subsidiary will remain a controlled subsidiary within Huaxin Cement's consolidated financial statements [1]. - The spin-off is deemed beneficial for the company's overall sustainable and stable development [1].

Core Viewpoint - Company is in the preliminary planning stage of a significant capital operation, focusing on the integration of its overseas assets for potential separate listing on foreign stock exchanges [1][2][3] Group 1: Financial Performance - For the first half of 2025, the company reported a net profit attributable to shareholders of 1.103 billion yuan, a year-on-year increase of 51.05% [2] - Overseas cement and clinker sales increased by 10.41% year-on-year, with overseas cement business revenue rising by 15.37% [2] - The overseas business contributed approximately 654 million yuan to the net profit, accounting for over 50% of the total net profit for the period [6][7] Group 2: Strategic Intent - The primary motivation for the planned spin-off is to create an independent and more market-efficient capital platform for the growing overseas business segment [5][6] - The company aims to broaden financing channels and enhance operational capabilities through the integration and listing of overseas assets [6][7] Group 3: Market Context - The company is shifting focus to overseas markets due to declining demand and severe overcapacity in the domestic cement industry [3] - As of June 30, 2025, the company has operations in 20 countries and 12 overseas production bases, with non-cement business EBITDA accounting for 44% [7] Group 4: Challenges and Uncertainties - The spin-off is still in the early planning stage and faces regulatory uncertainties, including compliance with domestic and international laws [8][9] - The company acknowledges potential risks from the international macro environment, including geopolitical conflicts and economic instability, which could impact overseas operations [8] - The execution of asset integration is complex, requiring coordination across different legal and regulatory frameworks [9]

Group 1 - The core viewpoint of the article is that Huaxin Cement (06655.HK) plans to integrate all its overseas assets engaged in production and operations into a new subsidiary, which will be established by Huaxin Cement or its affiliates, and intends to apply for a separate listing of this new subsidiary on an overseas stock exchange [1] - The spin-off listing will not affect Huaxin Cement's control over the relevant overseas assets, as the new subsidiary will still be included in Huaxin Cement's consolidated financial statements [1]

Group 1 - The core idea of the announcement is that Huaxin Cement plans to integrate all its overseas assets into a new subsidiary and apply for a separate listing on an overseas stock exchange to enhance its operational capabilities and financing channels [1] - The spin-off listing is expected to improve the competitiveness and flexibility of the new subsidiary in overseas capital markets, facilitating financing and merger transactions [1] - This strategic move is significant for enhancing Huaxin Cement's influence in the global cement production and sales industry, aligning with its long-term goal of becoming a leading multinational building materials enterprise [1] Group 2 - The announcement emphasizes that the spin-off will contribute to the overall sustainable and stable development of the company [1]

Core Viewpoint - Huaxin Cement plans to integrate all its overseas assets engaged in production and operation into a newly established overseas subsidiary, aiming to enhance its operational capabilities and broaden financing channels [1] Group 1: Business Strategy - The main business of the overseas assets to be integrated includes cement manufacturing and sales, cement technology services, production and sales of ready-mixed concrete and aggregates, and environmental services related to waste disposal in cement kilns [1] Group 2: Financial Implications - The company intends to apply for the overseas subsidiary to be listed on foreign stock exchanges, which may provide additional capital and improve financial flexibility [1]

Core Viewpoint - The company plans to integrate all its overseas assets engaged in production and operations into a newly established overseas subsidiary, which will be listed on an overseas stock exchange. This move aims to enhance financing channels, resource integration, operational capabilities, and global influence in the cement industry while aligning with the long-term strategic goal of becoming a leading multinational building materials enterprise [1]. Group 1 - The company intends to establish an overseas subsidiary for its operational assets [1] - The planned spin-off will not affect the company's control over the overseas assets, as the subsidiary will remain a consolidated subsidiary [1] - The initiative is part of the company's strategy to broaden financing options and improve operational efficiency [1]

Group 1 - The company has approved a proposal for the spin-off of its subsidiary, Yantai Lannacheng Biotechnology Co., Ltd., to be listed on the main board of the Hong Kong Stock Exchange [1] - The decision was made during the 13th meeting of the 6th Board of Directors held in Yantai, Shandong Province [1] - The company emphasizes the accuracy and completeness of the information disclosed, ensuring no false records or misleading statements [1] Group 2 - There are risks associated with the spin-off, including the potential for the process to be suspended or terminated due to an investigation for insider trading [1] - The approval process for the spin-off involves multiple steps, including internal decision-making, regulatory filings with the China Securities Regulatory Commission, and reviews by the Hong Kong Stock Exchange [1]

Group 1 - The core idea of the article is that CK Hutchison Holdings (00001) is considering a spin-off of its global telecommunications business for a potential listing in Hong Kong, with discussions already taking place with advisors including Citigroup and Goldman Sachs [1] - The company is also evaluating other options, such as selling parts of its regional telecommunications business or consolidating certain regional operations [1] - The potential spin-off could involve creating a new entity to manage telecommunications operations in Europe, Hong Kong, and Southeast Asia, with an estimated valuation of £10 billion to £15 billion [1] Group 2 - CK Hutchison's telecommunications business primarily includes the "3" Group in six European countries and a 66.09% stake in Hutchison Telecommunications Hong Kong Holdings [1] - The European "3" Group operates in the UK, Italy, Sweden, Denmark, Austria, and Ireland, while Hutchison Telecommunications has mobile telecommunications interests in Hong Kong and Macau [1]

Financial Data and Key Metrics Changes - Total operating expenses decreased from $3.9 million in 2024 to $2.6 million in 2025, a decline of 32.9% driven by lower general and administrative expenses, which fell by 37.4% to $1.2 million, and reduced research and development expenditure, down by 25.3% to $1.5 million [16] - Net loss decreased by 64.6% to $1.5 million in 2025 compared to $4.3 million in 2024, primarily due to finance income of $1.7 million from the appreciation of intercompany loans and lower finance expenses [16] - Cash used in operations decreased by 56.8% from $3.2 million in the first half of 2024 to $1.4 million in 2025 [16] - Shareholders' equity amounted to $4.1 million as of June 30, 2025, compared to $6.6 million at year-end 2024 [16] Business Line Data and Key Metrics Changes - The company is transitioning to a platform model focused on RNA delivery, which has led to a decrease in spending levels [15] - Significant progress in the RNA delivery business, with a focus on particle formulation and process development for various RNA platforms [7][10] - The company has established collaborations with multiple partners in the biotech and pharma industry, expanding its licensing strategy [11] Market Data and Key Metrics Changes - The circular RNA market is projected to grow at a rate of 15.2% from 2026 to 2033, potentially reaching $5.2 billion by 2033 [12] Company Strategy and Development Direction - The company plans to spin off a majority of its Swiss subsidiary, Altamira Therapeutics AG, to attract private equity investment, transitioning to a holding company model [5][6] - The focus will be on monetizing legacy assets while enhancing the RNA delivery business through partnerships and collaborations [5][19] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about the RNA delivery business's progress and the potential for growth, emphasizing the need for appropriate funding [18] - The decision to pursue a partial spin-off is seen as a beneficial alternative to accessing capital through public markets [18][19] Other Important Information - The company has made progress in transitioning its medical device, Ventrion, to comply with new EU regulations, with expected completion in late 2025 or early 2026 [14] - A patent for AM-125 nasal spray has been obtained in Japan, expanding intellectual property protection [14] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.